Scientists have synthetically engineered mosquitoes to prevent transmission of dengue virus to humans. This potentially could lead to genetic approaches to controlling the spread of dengue virus among populations.
As we head into 2020, we review the biggest outbreaks of 2019 and the impact they had – from growing cases of measles across the globe to the outbreaks as a result of ongoing instability in Yemen – take a look to find out more.
Take a look at this month’s industry headlines including results for Takeda’s dengue vaccine, approvals for Merck’s Ebola vaccine and the advent of a siderophore antibiotic – the first of this kind.
A team of researchers presented the first large-scale evidence that releasing Wolbachia-infected mosquitoes reduced dengue infections by >70% in high-risk populations.
Public Health England has confirmed cases of tick-borne encephalitis in two parts of the UK – Thetford forest and an area on the Dorset–Hampshire border.
Researchers may have discovered how Ebola invades our immune system and disrupts the host immune response.
Take a look at this month’s industry headlines including FDA warnings over hepatitis C drugs in patients with liver injury, a new infectious diseases strategy for the UK and priority review for Merck’s Ebola vaccine.
Health authorities in the Democratic Republic of Congo plan to introduce a second experimental Ebola vaccine, manufactured by Johnson & Johnson, from mid-October.
What impact will climate change have on vector-borne diseases? Discover more about rapid environmental and climate changes and the the distribution of vector-borne diseases in future.
The results of a new study suggest that – compared with the general population – Ebola survivors may be at a significantly increased risk of death, particularly during the first year following hospital discharge.
